Leaderboards/Retinal Diseases and Treatments

Retinal Diseases and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Ling Dai
ShanghaiTech University
2
Samiksha Pachade
The University of Texas Health Science Center
3
Mohammad Atwany
University of Oxford
4
Wejdan L. Alyoubi
King Abdulaziz University
5
Mohammed Oulhadj
Intelligent Systems Research (United States)
6
Maximilian McCann
University of Illinois Urbana-Champaign
7
Urvi Gupta
University of Pittsburgh
8
Huaping Tian
Chinese Academy of Medical Sciences & Peking Union Medical College
9
Sraddha Das
Vellore Institute of Technology University
10
N Jagan Mohan
National Institute Of Technology Silchar

Papers

1
A deep learning system for predicting time to progression of diabetic retinopathy
Nature Medicine|2024
302 cit.
2
Publication in Computers in Biology and Medicine (2024) [57 citations, W4395450210]
Computers in Biology and Medicine|2024
57 cit.
3
RFMiD: Retinal Image Analysis for multi-Disease Detection challenge
Medical Image Analysis|2024
14 cit.
4
Publication (2024) [6 citations, W4401508944]
Unknown Journal|2024
6 cit.
5
Publication (2024) [2 citations, W4403125140]
Unknown Journal|2024
2 cit.
6
Publication in Ophthalmic surgery, lasers & imaging retina (2024) [W4391565215]
Ophthalmic surgery, lasers & imaging retina|2024
0 cit.
7
Publication (2025) [W4416961245]
Unknown Journal|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Dale R. Webster
Google (United States)
2
Lily Peng
Google (United States)
3
Hrvoje Bogunović
Medical University of Vienna
4
Huating Li
Shanghai Sixth People's Hospital
5
Wesley T. Beaulieu
Jaeb Center for Health Research
6
Hong Kang
First Hospital of Lanzhou University
7
Waqas Jadoon
COMSATS University Islamabad
8
Arshad M. Khanani
University of Nevada, Reno
9
Stefano De Cillà
Piedmont University
10
Laura Vardoulakis
Google (United States)

Papers

1
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
The Lancet|2023
315 cit.
2
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota
Nature Metabolism|2024
205 cit.
3
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
Eye|2023
167 cit.
4
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
Eye|2023
130 cit.
5
Review of real-world evidence of dual inhibition of VEGF-A and ANG-2 with faricimab in NAMD and DME
International Journal of Retina and Vitreous|2024
83 cit.
6
MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
Ophthalmology|2022
71 cit.
7
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study
EClinicalMedicine|2023
67 cit.
8
Lessons learned from translating AI from development to deployment in healthcare
Nature Medicine|2023
63 cit.
9
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis
Eye|2022
41 cit.
10
Disease Activity and Therapeutic Response to Pegcetacoplan for Geographic Atrophy Identified by Deep Learning-Based Analysis of OCT
Ophthalmology|2024
36 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Tien Yin Wong
Beijing Tsinghua Chang Gung Hospital
2
Ursula Schmidt‐Erfurth
Medical University of Vienna
3
Peter A. Campochiaro
Johns Hopkins University
4
Srinivas R. Sadda
University of California, Los Angeles
5
K. Bailey Freund
Vitreous Retina Macula Consultants of New York
6
Philip J. Rosenfeld
University of Miami
7
Ronald Klein
University of Wisconsin–Madison
8
George L. King
Joslin Diabetes Center
9
Richard F. Spaide
Vitreous Retina Macula Consultants of New York
10
Jay S. Duker
Tufts Medical Center

Papers

1
Ranibizumab for Neovascular Age-Related Macular Degeneration
New England Journal of Medicine|2006
5.9k cit.
2
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
New England Journal of Medicine|1994
3.8k cit.
3
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Ophthalmology|2012
2.5k cit.
4
Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes
JAMA|2017
2.3k cit.
5
Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography
American Journal of Ophthalmology|2008
2.2k cit.
6
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Archives of Ophthalmology|1984
1.9k cit.
7
Prevalence of Age-related Maculopathy
Ophthalmology|1992
1.8k cit.
8
Clinical Classification of Age-related Macular Degeneration
Ophthalmology|2013
1.8k cit.
9
Age-related macular degeneration
The Lancet|2012
1.7k cit.
10
Retinal Vascular Layers Imaged by Fluorescein Angiography and Optical Coherence Tomography Angiography
JAMA Ophthalmology|2014
1.6k cit.

Reagents for Retinal Diseases and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Cytoskeletal Marker Antibody Sampler Kit

Cited in 17 papers
#8614$581
View Evidence →
Cell Signaling TechnologyEvidence 67

Total RIP3 Matched Antibody Pair II

Cited in 14 papers
#19570$1,726
View Evidence →
Cell Signaling Technology

Cyclophilin B (D1V5J) Rabbit Monoclonal Antibody

Cited in 14 papers
#43603$173,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 63

Phospho-RRM2 (Thr33) (F1B6L) Rabbit Monoclonal Antibody

Cited in 22 papers
#72737$176,437
View Evidence →
Cell Signaling TechnologyEvidence 69

Helios (D8W4X) Rabbit Monoclonal Antibody (mFluor™ UV375 Conjugate)

Cited in 19 papers
#16012$465
View Evidence →
Cell Signaling TechnologyEvidence 72

CD11c (D3V1E) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 19 papers
#95103$180,465
View Evidence →